Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

Scheiner, Bernhard; Roessler, Daniel; Phen, Samuel; Lim, Mir; Pomej, Katharina; Pressiani, Tiziana; Cammarota, Antonella; Fründt, Thorben W.; von Felden, Johann; Schulze, Kornelius; Himmelsbach, Vera; Finkelmeier, Fabian; Deibel, Ansgar; Siebenhüner, Alexander R.; Shmanko, Kateryna; Radu, Pompilia; Schwacha-Eipper, Birgit; Ebert, Matthias P.; Teufel, Andreas; Djanani, Angela; ... (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma. JHEP reports, 5(1), p. 100620. Elsevier 10.1016/j.jhepr.2022.100620

Text
1-s2.0-S2589555922001926-main__1_.pdf - Accepted Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (2MB)

Preview

Text
1-s2.0-S2589555922001926-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).
Download (736kB) | Preview

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
UniBE Contributor:	Radu, Iuliana Pompilia, Schwacha-Eipper, Birgit, Dufour, Jean-François
Subjects:	600 Technology > 610 Medicine & health
ISSN:	2589-5559
Publisher:	Elsevier
Language:	English
Submitter:	Rahel Fuhrer
Date Deposited:	09 Jan 2023 10:56
Last Modified:	15 Jan 2023 02:18
Publisher DOI:	10.1016/j.jhepr.2022.100620
PubMed ID:	36578451
BORIS DOI:	10.48350/176555
URI:	https://boris.unibe.ch/id/eprint/176555

Actions (login required)

Edit item

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

Interest & Impact

Downloads

Citations

Search

Services

Actions (login required)

Item Type:

Division/Institute:

UniBE Contributor:

Subjects:

ISSN:

Publisher:

Language:

Submitter:

Date Deposited:

Last Modified:

Publisher DOI:

PubMed ID:

BORIS DOI:

URI:

Actions (login required)